Literature DB >> 27884311

Understanding kidney care needs and implementation strategies in low- and middle-income countries: conclusions from a "Kidney Disease: Improving Global Outcomes" (KDIGO) Controversies Conference.

Vivekanand Jha1, Mustafa Arici2, Allan J Collins3, Guillermo Garcia-Garcia4, Brenda R Hemmelgarn5, Tazeen H Jafar6, Roberto Pecoits-Filho7, Laura Sola8, Charles R Swanepoel9, Irma Tchokhonelidze10, Angela Yee Moon Wang11, Bertram L Kasiske12, David C Wheeler13, Goce Spasovski14.   

Abstract

Evidence-based cinical practice guidelines improve delivery of uniform care to patients with and at risk of developing kidney disease, thereby reducing disease burden and improving outcomes. These guidelines are not well-integrated into care delivery systems in most low- and middle-income countries (LMICs). The KDIGO Controversies Conference on Implementation Strategies in LMIC reviewed the current state of knowledge in order to define a road map to improve the implementation of guideline-based kidney care in LMICs. An international group of multidisciplinary experts in nephrology, epidemiology, health economics, implementation science, health systems, policy, and research identified key issues related to guideline implementation. The issues examined included the current kidney disease burden in the context of health systems in LMIC, arguments for developing policies to implement guideline-based care, innovations to improve kidney care, and the process of guideline adaptation to suit local needs. This executive summary serves as a resource to guide future work, including a pathway for adapting existing guidelines in different geographical regions.
Copyright © 2016 International Society of Nephrology. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  acute kidney injury; advocacy; chronic kidney disease; clinical practice guidelines; implementation; low and middle income countries

Mesh:

Year:  2016        PMID: 27884311     DOI: 10.1016/j.kint.2016.09.009

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  28 in total

Review 1.  Considerations on equity in management of end-stage kidney disease in low- and middle-income countries.

Authors:  Wim Van Biesen; Vivekanand Jha; Ali K Abu-Alfa; Sharon P Andreoli; Gloria Ashuntantang; Bassam Bernieh; Edwina Brown; Yuqing Chen; Rosanna Coppo; Cecile Couchoud; Brett Cullis; Walter Douthat; Felicia U Eke; Brenda Hemmelgarn; Fan Fan Hou; Nathan W Levin; Valerie A Luyckx; Rachael L Morton; Mohammed Rafique Moosa; Fliss E M Murtagh; Marie Richards; Eric Rondeau; Daniel Schneditz; Kamal D Shah; Vladimir Tesar; Karen Yeates; Guillermo Garcia Garcia
Journal:  Kidney Int Suppl (2011)       Date:  2020-02-19

2.  Assessment of Global Kidney Health Care Status.

Authors:  Aminu K Bello; Adeera Levin; Marcello Tonelli; Ikechi G Okpechi; John Feehally; David Harris; Kailash Jindal; Babatunde L Salako; Ahmed Rateb; Mohamed A Osman; Bilal Qarni; Syed Saad; Meaghan Lunney; Natasha Wiebe; Feng Ye; David W Johnson
Journal:  JAMA       Date:  2017-05-09       Impact factor: 56.272

Review 3.  Framework for establishing integrated kidney care programs in low- and middle-income countries.

Authors:  Marcello Tonelli; Victoria Nkunu; Cherian Varghese; Ali K Abu-Alfa; Mona N Alrukhaimi; Louise Fox; John Gill; David C H Harris; Fan Fan Hou; Philip J O'Connell; Harun Ur Rashid; Abdou Niang; Shahrzad Ossareh; Vladimir Tesar; Elena Zakharova; Chih-Wei Yang
Journal:  Kidney Int Suppl (2011)       Date:  2020-02-19

4.  Dipstick proteinuria and all-cause mortality among the general population.

Authors:  Kunitoshi Iseki; Tsuneo Konta; Koichi Asahi; Kunihiro Yamagata; Shouichi Fujimoto; Kazuhiko Tsuruya; Ichiei Narita; Masato Kasahara; Yugo Shibagaki; Toshiki Moriyama; Masahide Kondo; Chiho Iseki; Tsuyoshi Watanabe
Journal:  Clin Exp Nephrol       Date:  2018-06-05       Impact factor: 2.801

Review 5.  Immunity, microbiota and kidney disease.

Authors:  Felix Knauf; J Richard Brewer; Richard A Flavell
Journal:  Nat Rev Nephrol       Date:  2019-05       Impact factor: 28.314

6.  AKI!Now Initiative: Recommendations for Awareness, Recognition, and Management of AKI.

Authors:  Kathleen D Liu; Stuart L Goldstein; Anitha Vijayan; Chirag R Parikh; Kianoush Kashani; Mark D Okusa; Anupam Agarwal; Jorge Cerdá
Journal:  Clin J Am Soc Nephrol       Date:  2020-04-21       Impact factor: 8.237

7.  Availability and Affordability of Kidney Health Laboratory Tests around the Globe.

Authors:  Sri Lekha Tummalapalli; Michael G Shlipak; Sandrine Damster; Vivekanand Jha; Charu Malik; Adeera Levin; David W Johnson; Aminu K Bello
Journal:  Am J Nephrol       Date:  2020-12-17       Impact factor: 3.754

8.  Diagnostic accuracy of semiquantitative point of care urine albumin to creatinine ratio and urine dipstick analysis in a primary care resource limited setting in South Africa.

Authors:  June Fabian; Jaya A George; Sean D Currin; Mwawi S Gondwe; Nokthula B Mayindi; Shingirai Chipungu; Bongekile L Khoza; Stephen Tollman
Journal:  BMC Nephrol       Date:  2021-03-20       Impact factor: 2.388

Review 9.  Challenges for sustainable end-stage kidney disease care in low-middle-income countries: the problem of the workforce.

Authors:  Charles R Swanepoel; Mignon I McCulloch; Georgi Abraham; Jo-Ann Donner; Mona N Alrukhaimi; Peter G Blake; Sakarn Bunnag; Stefaan Claus; Gavin Dreyer; Mohammad A Ghnaimat; Fuad M Ibhais; Adrian Liew; Marla McKnight; Yewondwossen Tadesse Mengistu; Saraladevi Naicker; Abdou Niang; Gregorio T Obrador; Jeffrey Perl; Harun Ur Rashid; Marcello Tonelli; Kriang Tungsanga; Tushar Vachharajani; Elena Zakharova; Carlos Zuniga; Fredric O Finkelstein
Journal:  Kidney Int Suppl (2011)       Date:  2020-02-19

Review 10.  Dysbiosis-Related Advanced Glycation Endproducts and Trimethylamine N-Oxide in Chronic Kidney Disease.

Authors:  Kensei Taguchi; Kei Fukami; Bertha C Elias; Craig R Brooks
Journal:  Toxins (Basel)       Date:  2021-05-19       Impact factor: 4.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.